Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands. by Mecsas, J. J. & Strauss, E. J.
271 Vol. 2, No. 4—October-December 1996 Emerging Infectious Diseases
Synopses
Discovery of Two Traits Used by a Broad
Range of Bacterial Pathogens
In the past decade, there has been an
explosion of new information about bacterial
pathogens as researchers have begun to
examine the molecular and genetic bases of
microbial pathogenicity. Because microbes
invade many niches in humans and cause a
wide variety of syndromes, it initially
appeared that each disease might be created
by a distinct molecular mechanism. However,
the spectrum of methods is not as broad as
first imagined; rather, bacteria exploit a
number of common molecular tools to achieve
a range of goals (1). Among these tools are
pathogenicity islands, which enable bacteria
to gain complex virulence traits in one step,
and type III secretion systems, which
provide a means for bacteria to target
virulence factors directly at host cells. These
factors then tamper with host cell functions
to the pathogens’ benefit.
Early in the search for virulence genes,
researchers discovered that many of these
genes resided on plasmids or phages;
however, it was also clear that these genes
did not produce all of the physiologic changes
induced in host cells by various pathogens
(2). Thus, researchers searched the
chromosome. Surprisingly, as when found on
plasmids, virulence genes often clustered in
functionally related groups. Furthermore,
these groups often appeared to have been
acquired from another organism, as features
of their DNA sequence differed from the bulk
of the genome. These observations gave rise
to the concept of pathogenicity islands—
discrete segments of DNA that encode
virulence traits and often appear to have a
foreign origin (3,4).
Researchers found that a particular set of
virulence genes appeared several times on
both plasmids and pathogenicity islands (5-
8). These genes were discovered in both plant
and animal pathogens and were homologous
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Recently, two novel but widespread themes have emerged in the field of bacterial
virulence: type III secretion systems and pathogenicity islands. Type III secretion
systems, which are found in various gram-negative organisms, are specialized for the
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normal host cell functions in ways that seem beneficial to invading bacteria. The
genes encoding several type III secretion systems reside on pathogenicity islands,
which are inserted DNA segments within the chromosome that confer upon the host
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provides a mechanism for sudden radical changes in bacterial-host interactions. Type
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evolution of known pathogens and are likely to lead to the emergence of novel
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to genes encoded on a virulence plasmid of
pathogenic  Yersinia spp. (Table 1) (9-12).
The  Yersinia proteins are the components of
a novel secretion system (13), called type III
(14). This machinery propels effector
molecules toward host cells where they alter
host physiology (15,16). The homology
suggested that many divergent bacterial
pathogens had acquired a similar system
from a common source. Pathogens use the
type III system to secrete different effector
molecules that influence host cells in a
variety of ways (16-19).
Secretion Systems in Bacteria
Secreted or surface-exposed bacterial
proteins have long been known to play
central roles in bacterial-host interactions.
In gram-negative bacteria, these proteins
must pass through two membranes: the
inner membrane, which surrounds the
cytoplasm, and the outer envelope, which
encloses the periplasm and acts as a barrier
to the environment (Figure 1). The general
secretory pathway transports proteins to the
periplasm. Before the  Yersinia secretion
system was identified, two other specialized
secretion systems, type I and type II, were
Figure 1: Schematic diagram of type I, type II, and type III secretion systems. All systems use the energy of
ATP hydrolysis to drive secretion. Type I and type III secrete proteins across both the inner membrane and
the cell envelope (outer membrane) in one step; secreted proteins do not make an intermediate stop in the
periplasm, as they do in type II secretion. Type I and type III systems are also similar in that they do not
remove any part of the secreted protein. In contrast, the N-terminus of proteins secreted by the general
secretory pathway is removed upon transfer to the periplasm; the N-terminal signal sequence can be seen in
the periplasm, and the extracellular protein is clearly different from the intracellular protein by virtue of its
absence. Type I systems are composed of far fewer components than type III systems; this is indicated by the
number of distinct proteins (indicated by shape and size) in the figure. Type II and type III systems share a
similar cell envelope component, as indicated by sequence homology; this is reflected in the shape of a cell
envelope component in the figure.273 Vol. 2, No. 4—October-December 1996 Emerging Infectious Diseases
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known to transport molecules to the cell
surface (14,20,21). Proteins secreted by the
Type I system cross directly from the
cytoplasm to the cell surface, bypassing the
general secretory pathway completely
(Figure 1). Type II-secreted proteins use the
general secretory pathway to reach the peri-
plasm and then traverse the outer membrane
through distinct channel proteins. Both type
I and type II systems secrete proteins invol-
ved in various functions, including patho-
genesis. For example, a-hemolysin of E. coli
uses a type I system and bundle-forming pili
of enteropathogenic  E. coli ( EPEC) and
enterotoxigenic E. coli ( ETEC) use type II
systems for export.
In the past 5 years, the highly conserved,
multicomponent type III secretion system
has been found in many gram-negative
bacteria that cause disease in animals and
plants (8). This secretion system is
responsible for transporting effector
molecules directly from the cytoplasm to the
cell surface, where they interact with
mammalian cells and modify host cell
proteins (13). This one-step secretion process
is reminiscent of the mechanism used by
type I  systems (Figure 1). The genes that
encode many components of type III systems
are homologous to those that encode flagellar
export machinery in both gram-negative and
gram-positive bacteria (Table 1) (22-24).
Indeed, these two systems share many
structural and functional features. The
differences reside at the outer membrane.
Flagellar components pass through an outer
ring structure that is part of the flagellum
itself (23), whereas pathogenic effector
molecules traverse the outer membrane
through a channel protein that is homologous
to those used in type II secretion systems
(20,25). While our discussion of type III
secretion systems will focus primarily on
those used by human pathogens, many
characteristics are common among systems
found in plant pathogens and bacteria that
produce flagella.
Type III Systems Secrete Effector Proteins
Upon Contacting Host Cells
In contrast to the secretion process in
type I and type II systems, type III secretion
is triggered when a pathogen comes in close
contact with host cells (18,19,26,27), and
hence, has been called contact-dependent
secretion (28). Temperature, growth phase,
and salt conditions are environmental cues
known to induce synthesis of the secretion
apparatus and effector molecules in various
pathogens (29-31). When the pathogen comes
into close contact with tissue culture cells,
effector molecules move to the external
surface of the bacterium, sometimes forming
appendages suggestive of flagellae (18). In
some cases, the bacterium binds to the host
cells and these molecules are delivered into
the host cell (32). The effector molecules
cause changes in host cell function, which
facilitate the pathogen’s ability to survive
and replicate (15-17,33).
How Pathogens Use Type III Secretion
Systems in the Host
The best studied bacterial pathogens
that use type III secretion are  Yersinia
pestis, which causes plague, and a number of
enteropathogens. Although these various
enteropathogens (Yersinia spp., Salmonella
spp., Shigella spp., and EPEC) cause
diarrhea and, in some cases, systemic
disease, they produce distinct syndromes
because their secreted proteins target
different host cells and molecules (Table 1)
(34).
Yersinia spp. use their effector molecules
to destroy key functions of immune cells and
render them innocuous (35). When these
bacteria bind to tissue culture cells,
approximately 10 different effector molecules
are secreted (13) and at least three are
injected into cells (27,36-38). Two of these
injected molecules, YopE and YopH, modify
macrophage proteins and destroy the cells’
abilities to engulf and kill bacteria (16,39).
During the course of disease, immune cells
are presumably neutralized by these effector
molecules, which enables  Yersinia spp. to
flourish in the reticuloendothelial
environment.
While effector molecules in  Yersinia
destroy normal cellular functions, those from
Shigella spp. and from one of the Salmonella
spp. type III secretion systems, encoded by
genes located in SPI I (Table 2), stimulate274 Emerging Infectious Diseases Vol. 2, No. 4—October-December 1996
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cells to perform functions in addition to those
in their usual repertoires. Studies in
epithelial tissue culture systems show that
these bacteria induce their own entry into
normally nonphagocytic cells by using
effector molecules secreted by their type III
systems (28,40). During the course of
disease,  Shigella  spp. enter and replicate in
the mucosal epithelial cells of the large
intestine, while Salmonella spp. gain entry
into the peritoneal cavity by passing through
the epitheloid-like M cells in the small
intestine (41). In the murine model for
typhoid fever,  S. typhimurium that are
defective in this secretion system are
attenuated for infection when administered
orally, but not intraperitoneally (42).
Presumably this attenuation is a consequence
of reduced entry into the M cells in the small
intestine, a barrier that is bypassed by
intraperitoneal delivery.
Although neither its effector molecules
nor target host cells have been identified, a
second type III secretion system, encoded by
genes located in SPI II (Table 2), has been
described in S. typhimurium, on the basis of
sequence homology (43). The genes in SPI II,
in contrast to those in SPI I, are required for
systemic disease regardless of the route of
infection (43,44). Presumably the factors
encoded in SPI II act after the bacteria have
crossed the epithelial barrier of the small
intestine.
Although the functions and sites of action
of the secretion systems differ among these
enteric pathogens, effector molecules from
one system can be secreted by other systems,
provided the appropriate chaperones are
present. Such heterologously expressed
effector molecules can induce the same
cellular response as when expressed from
their native systems. For instance, an
effector molecule from Yersinia that causes
actin depolymerization has the same effect
on tissue culture cells when secreted from
Salmonella (45). Likewise, proteins of
Shigella and Salmonella involved in bacterial
uptake into cultured epithelial cells are
functionally interchangeable (46).
 The observation that  Salmonella spp.
have two contact-dependent systems that
function at distinct stages to cause disease
raises several interesting questions. Why do
Salmonella  spp. need different type III
secretion apparatuses when it is clear that
effector molecules can be secreted from
heterologous systems? Could one suffice if
the two sets of effector molecules were
expressed at appropriate times during the
course of infection? Alternatively, do these
two sets of effector molecules need to be
delivered to different target cells in a specific
manner, which is only possible with distinctly
customized machinery? Answers to these
questions will illuminate issues about both
the course of salmonellosis and the basic
mechanics of the secretion apparatus.
The Nuts and Bolts of Type III Secretion
The type III secretion apparatus in
Yersinia  spp. has been the most intensively
investigated. However, this work has been
done in three  Yersinia spp; thus several
proteins have been shown to be essential for
effector molecule secretion in one species but
have not yet been examined in others. Our
analysis of these studies assumes that
proteins essential in one will play a similar
role in all (Table 1).
One essential feature of any secretion
system is that energy must be provided to
move molecules through the membrane (14).
Only one protein in the system, YscN, has
been shown to hydrolyze ATP and thus is a
likely candidate for generating energy to
drive secretion (47). YscN is predicted to be a
cytoplasmic protein, closely associated with
the inner membrane.
Several proteins essential to secretion
including LcrD, YscD, R, S, T, and U, are
known or predicted to reside in the inner
membrane (10,12,48-50). At the outer
membrane, only one protein, YscC (48), and
two lipoproteins, YscJ and VirG (51,52),
appear essential for proper secretion. The
roles and subcellular locations are not known
for several more essential proteins, YscE, F,
G, I, K, and L (9,48,51). How all of these
proteins interact with one another to form
the secretion apparatus is not yet understood.
It is clear, however, that correct assembly of
the apparatus is required not only for
secretion, but also for normal synthesis of
effector molecules (47,48). If one component
of the export machinery is missing, production
of the effector molecules is altered. This279 Vol. 2, No. 4—October-December 1996 Emerging Infectious Diseases
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feedback regulation also occurs in systems
that produce flagella (53). How it works in
Yersinia is under investigation; thus far,
only one protein, LcrQ, has been implicated
(54).
Two proteins, YopB and YopD, are
loosely associated with the outer membrane
(55) and are crucial for efficient delivery of
effector molecules into target cells. These
two proteins use the type III secretion
system to reach the bacterial cell surface.
Without YopB, which has homology to pore-
forming toxins (55), and YopD, effector
molecules are secreted but not efficiently
internalized by host cells; thus, their
activities on host cells are severely abrogated
(27,36). Presumably, YopB and YopD form a
pore in the mammalian cell through which
effector molecules pass.
Several proteins, called chaperones, play
critical roles in secretion by binding to
effector molecules in the bacterial cytoplasm.
Chaperones have several proposed functions
(56-58). Chaperone binding may stabilize
and prevent proteins from folding into
conformations that are impossible to secrete.
Alternatively, as has been shown for
Shigella, they may prevent effector molecules
from improperly associating with one another
before secretion (58). Lastly, chaperones may
deliver molecules to the secretion apparatus.
In addition to the feedback regulation
mentioned above, the synthesis of and secre-
tion from the  Yersinia type III system is
regulated by two networks that respond to
environmental cues (29,35). A temperature-
sensing network induces synthesis of the
apparatus at 37°C and includes VirF and
YmoA (35). A host cell-sensing network
increases both synthesis of and secretion
from the type III system when Yersinia binds
to target cells. This regulatory system is
called the low-calcium response network—
low calcium presumably mimics some signal
generated by cell contact—and includes
YopN, LcrG, and LcrQ (32,54,59,60). YopN
localizes to the outer membrane, where it
senses cell contact and transduces this
signal to the cytoplasm by an unknown
mechanism (60). The role of LcrG has not yet
been elucidated. LcrQ functions as a
repressor of the Yops. When Yersinia comes
into close contact with host cells, LcrQ is
secreted from the cytoplasm through the
type III secretion system. This lowers the
intracellular concentration of LcrQ and
results in an increase in synthesis and
secretion of the Yops (32). Flagella synthesis
is controlled in a similar manner (61).
Many of the structural components of the
Yersinia system have homologues in Shigella,
Salmonella, and  EPEC (Table 1). A
comparison of proteins found in each system
shows that certain core structural components
are present in all type III apparatuses,
whereas others may exist in only one or a
subset. These differences may be due to
particular functions of each system.
Several studies have examined whether
structural components from different bacteria
are interchangable. In general, core
constituents from  Shigella and SPI I of
Salmonella, which both facilitate bacterial
uptake by epithelial cells, are interchangable
with one another, but not with those in the
Yersinia system (7,62). These results may be
due to the observation that factors from
Shigella and SPI I of  Salmonella are pre-
dicted by sequence homology to be more
structurally similar to each other than to
those in Yersinia (7). Alternatively, some of
the regulatory cues for secretion and assem-
bly may be different for Yersinia than for
Salmonella and Shigella.
Most proteins in the type III secretion
systems, including effector proteins,
regulatory proteins, structural proteins, and
chaperones (Table 1), are encoded by genes
that belong to several large operons, which
are clustered together (7,9,12,63). These
operons are on plasmids in some species, and
on the chromosome in others (Table 1). In
some cases, such as in Shigella and SPI I of
Salmonella, the order of the genes within
operons and the arrangement of the operons
with respect to each other are conserved (7).
These observations suggest that type III
systems were inherited en masse, and
likewise, could be transmitted to other
bacteria en masse. One can speculate that
the acquisition of a type III secretion system
could allow a bacterium to adapt to different
environments or hosts. For instance, a new
pathogen could perhaps arise if a skin-
commensal bacterium were to acquire the
means to penetrate and survive in the skin-280 Emerging Infectious Diseases Vol. 2, No. 4—October-December 1996
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associated lymphoid tissue by obtaining a
type III secretion system from an entero-
pathogen.
Where Do Type III Secretion Systems Come
From?
It seems plausible that the original type
III secretion system for virulence factors
evolved from those for flagellar assembly
(22,53). The bacterial flagellum exists in a
wide range of eubacteria and some
archaebacteria, which indicates that it
probably emerged well before gram-negative
bacteria, the hosts of the type III virulence
factor secretion systems identified thus far.
Attempts to establish any of the known
type III secretion systems as the progenitor
have been fruitless. On the basis of degrees
of homology among different type III systems
and well-established evolutionary
relationships between the bacteria, each
organism can be ruled out as the source (64).
For example, Shigella emerged from E. coli
after Salmonella and E. coli diverged from a
common ancestor; thus, Shigella cannot have
provided the type III systems conserved in
the Salmonella spp. Conversely, as Shigella
type III apparatus sequences have a G+C
content well below that of Salmonella and of
the bulk of the  Shigella chromosome,
Salmonella could not have been the source of
the  Shigella genes (Table 2). Thus, the
ability to secrete effector molecules by this
mechanism seems to have been introduced
independently into each of these bacteria.
Examination of homologous genes in the
epithelial cell invasion loci of  Salmonella
and  Shigella shows that some are highly
conserved, while others display much lower
levels of homology (65). Li and colleagues
have found a relationship between
evolutionary rate of change and subcellular
location: genes encoding several secreted
proteins are hypervariable in relation to
genes encoding several proteins located in
the bacterial inner membrane (65). In
principle, hypervariability could reflect
antigenic variation or adaptations to diverse
host environments; however, neither of these
explanations appears to pertain to the
particular proteins examined (28,65).
Type III systems sometimes provide
much of what distinguishes particular
organisms from closely related, often
nonpathogenic, species. As described above,
many operons encoding type III secretion
machinery are clustered. DNA sequence
analysis has shown that these loci are often
distinguishable from the bulk of the genomic
DNA. The loci that are chromosomally
located represent “pathogenicity islands”
(66).
History and Definition of “Pathogenicity
Islands”
The phrase “pathogenicity island” was
first used to describe two large, unstable
pieces of chromosomal DNA, unique to
uropathogenic  E. coli, that encode a number
of genes required for virulence (3,4). Since its
conception, the term has evolved to include
regions of chromosomal DNA essential for
pathogenicity that do not appear to “belong”
(Table 2). Not all pathogenicity islands are
genetically unstable, but each one shows an
indication of foreign origin. These pieces of
DNA are often missing in closely related,
nonvirulent bacteria. Many pathogenicity
islands differ from the bulk of the genome in
G+C content and codon usage, and their
borders are often marked by repeated
sequences or insertion elements, which
suggests that some kind of recombination
event delivered them to the chromosome.
Several encode multiple proteins that
collaborate to confer a single, complex
virulence property to the bacterial host.
The definition of pathogenicity islands
includes chromosomal location. As such, the
plasmid-borne type III gene clusters of
Yersinia and Shigella do not qualify (Table 1).
This seems somewhat arbitrary. Indeed,
phages and a number of plasmids can easily
insert into and excise from the chromosome.
Similarly, many transposable elements
replicate and function equally as well in the
chromosome as on an extrachromosomal
element. It seems to us that a block of
apparently foreign genes found uniquely in
pathogenic members of a genus and required
for virulence is a more useful and relevent
defining feature of a pathogenicity island
than location. Thus, it makes sense to
include the loci encoding type III secretion
systems, regardless of whether they reside
on a plasmid or chromosome. In the281 Vol. 2, No. 4—October-December 1996 Emerging Infectious Diseases
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discussion below, however, we adhere to the
established definition that includes chromo-
somal location.
Pathogenicity Islands Contain Virulence
Genes and Regulatory Elements
Pathogenicity islands also contain
virulence genes other than those encoding
type III secretion systems; a common theme
appears to be inclusion of genes for secreted
or cell surface-localized proteins such as
hemolysins, fimbriae, and hemin-binding
factors (Table 2). In fact, the similarities
between pathogenicity islands extend further:
examination of the large ones shows that
many also contain genes that encode a
secretion system and environmental sensors.
They also can include proteins that regulate
expression of genes that lie outside the
pathogenicity island. For example,
pathogenicity island II (Pai II) of uropatho-
genic  E. coli contains genes that encode
transcriptional activators of S-fimbrial genes
that reside at a chromosomal locus remote
from either of the known pathogenicity
islands in this species (67).
Pathogenicity Islands Can Exist in Various
Structural Types and Numbers Within a
Bacterium
A single bacterial strain can harbor more
than one pathogenicity island. Salmonella
contains at least five: the gene clusters
encoding the two type III secretion systems
described above, sifA (see below), and two
groups of genes that are activated by the two-
component regulator, PhoP/PhoQ. These loci
vary in size and complexity and reside at
distinct chromosomal locations (43,68,69,
and S. Miller, pers. comm.).
Pathogenicity islands themselves can be
composed of distinct segments. For example,
an unstable 102-kb region of DNA that
encodes several traits important for virulence
of  Y. pestis appears to consist of several
regions (70-72). One contains the hemin
storage genes and has a G+C content similar
to that of the bulk of the chromosome (R.
Perry, pers. comm.); the other contains genes
encoding the Yersiniabactin receptor and
iron-regulated proteins and has a
significantly higher G+C content (R. Perry,
pers. comm) (73). Although the 102 kb region
often deletes entirely, the two regions can
also act independently. In some strains the
chromosomal region containing the hemin
storage genes spontaneously deletes from
the chromosome at a significant frequency,
while the Yersiniabactin receptor/iron-regu-
lated protein region appears stable (72).
Furthermore, only the Yersiniabactin
receptor/iron-regulated segment is present
in  Y. enterocolitica (70).
Even more complex pathogenicity islands
are harbored by strains of  Helicobacter
pylori, the causative agent of gastritis and
peptic ulcer disease in humans. Strains of H.
pylori  have been divided into two classes:
type I strains express the cytotoxin-asso-
ciated gene A (CagA) antigen and induce
secretion of the neutrophil attractant IL-8 by
epithelial cells in vitro, while type II strains
lack both of these properties. Patients with
duodenitis, duodenal ulcers, and gastric
tumors are most often infected by type I
strains. Likewise, type I strains are more
likely than type II strains to cause gastric
injuries in murine model systems. Analysis
of the chromosomal region that contains the
cagA gene has shown that it is a pathogenicity
island of approximately 40 kb of DNA,
missing in type II strains, and that muta-
tions in this region abolish IL-8 induction in
gastric epithelial cell lines (Censini, S et al.
A pathogenicity island of Helicobacter pylori,
encodes type I-specific and disease-associated
factors. 1996; submitted for publication).
Different type I strains display con-
siderable heterogeneity in the cag region
(Censini, S et al. A pathogenicity island of
Helicobacter pylori, encodes type I-specific
and disease-associated factors. 1996;
submitted for publication). In some isolates,
the cag region is interrupted by one or more
insertion sequences. In a small number of
strains, there is an additional 20-kb
sequence that is also present in type II
strains. Partial deletions of the cag region
have been detected as well. Thus, the cag
pathogenicity island appears to be undergoing
dynamic changes in natural  Helicobacter
populations. Further study of the cag region
may elucidate details of pathogenicity island282 Emerging Infectious Diseases Vol. 2, No. 4—October-December 1996
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acquisition and help correlate regions of the
pathogenicity island with disease symptoms
in the murine model system.
Since its establishment, the definition of
pathogenicity islands has evolved to include
genetic regions that are neither large nor
complex; single genes of apparently foreign
origin can also be inserted into chromosomal
DNA.  S. typhimurium has recently been
shown to contain such a gene, called sifA,
which is required for formation of distinctive
structures associated with  Salmonella-
containing vacuoles within epithelial cells
and contributes to pathogenicity in the
murine typhoid fever model system (Table 2)
(69).
Possible Origins of Pathogenicity Island
DNA and Mechanisms of Transfer and
Insertion
While the sources of pathogenicity
islands are unknown, their presence in a
wide variety of organisms (Table 2) indicates
that bacteria can acquire DNA despite
multiple barriers to chromosomal gene
transfer between species. The existence of
“foreign” genomic DNA is particularly
intriguing as sequence divergence is a major
limitation to such transfers because it
severely limits the potential for homologous
recombination (74).
Although the identity of the vectors that
transport pathogenicity islands from donor
to recipient organisms is unknown, any
number of mobile genetic elements are
candidates. Clear evidence showing an
extrachromosomal stage of a pathogenicity
island is lacking; however, it is intriguing
that the G+C contents of the  Helicobacter
pathogenicity island and plasmid are similar
to each other and distinct from the
chromosome (Censini, S et al. A pathogenicity
island of Helicobacter pylori, encodes type I-
specific and disease-associated factors. 1996;
submitted for publication).  Phages, plasmids,
transposons, integrons, and even free DNA
carry genes from one organism to another
(74). Indeed, many phages and plasmids
contain virulence genes, and often these loci
seem alien to the bacterial species in which
they reside (75). Furthermore, the animal
host environment may be particularly
conducive to DNA transfer events. For
example, the phage that encodes cholera
toxin infects  V. cholerae more efficiently
within the gastrointestinal tract of a
mammalian host than under laboratory
conditions (76).
Pathogenicity islands insert into the
chromosome by an unknown mechanism;
however, the existence of insertion elements
and repeated DNA motifs at the boundaries
of several pathogenicity islands suggest that
recombination events are involved. Recombi-
nation has recently been shown to be the
major factor governing the divergence of a
group of E. coli strains and is a significant
driving force for evolution (74,77). Although
the genetic material comprising pathogenicity
islands may be introduced into a new host
organism in a single step, the events that
generate known pathogenicity islands are
unlikely to be simple insertions, because
DNA rearrangements and alterations are
common in the flanking chromosomal regions.
The identification of several tRNA genes
as insertion sites for pathogenicity islands is
also notable, although the significance of
this remains obscure (Table 2). tRNA genes
serve as integration sites for a variety of
prokaryotic genetic elements, including
several phages and transmissible plasmids
(78-80). Perhaps the conserved portion of
tRNA genes is a useful landmark for mobile
genetic elements that inhabit a variety of
prokaryotic hosts; in addition, the regions of
dyad symmetry characteristic of all tRNA
genes could serve as binding sites for
enzymes involved in recombination.
Relative Advantages of Instability and
Stability
Some pathogenicity islands can excise
from the chromosome and are apparently lost
from the host bacterium (Table 2) (3,4,70).
Such instability may provide an adaptive
advantage. Virulence properties may be
dispensable at certain stages of infection,
and the coordinated loss of these
characteristics could be beneficial to the
bacterium. Indeed, expression of particular
genes at inappropriate times can be
detrimental to bacterial pathogens (81).
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virulence regions can occur in specific
environments: diabetic patients are more
susceptible to uropathogenic E. coli strains
not exhibiting virulence phenotypes (4).
On the other hand, particular virulence
traits could provide a continual adaptive
advantage, resulting in stable pathogenicity
islands. The “foreign nature” of pathogenicity
islands may reflect this benefit; foreign DNA
may be actively maintained in the population
because of its limited ability to recombine
with related organisms (75). It is not clear
whether stable islands exist because of a
divergence of sequences at the borders (for
example, repeated elements that are no
longer recognizable as such), an integration
mechanism completely different from that of
the unstable islands, or because of a lack of
excision machinery.
Deletion of pathogenicity islands can
affect gene expression by altering the
chromosomal site of insertion and by
removing the genes contained in the island.
The locus of enterocyte effacement (LEE)
comprising the type III secretion apparatus
in EPEC and pathogenicity island I (Pai I) of
uropathogenic  E. coli both insert at the
selenocysteine tRNA (selC) gene (82,83). The
presence of Pai I does not interfere with selC
expression. However, excision from the
chromosome appears to occur by a
recombination event between the repeated
sequences in selC and the distal end of Pai I.
This recombination event results in deletion
of part of the tRNA gene and inhibits
anaerobic growth due to the cell’s inability to
produce formate dehydrogenase, which
contains selenocysteine (84). Similarly, in
Pai II deletion strains, the leuX tRNA gene
at the insertion site is disrupted, which
interferes with its ability to act as a global
regulator of several virulence factors that lie
outside the pathogenicity island (84).
Bacteria may be able to have the best of
both the stable and the unstable worlds. The
phenotypic loss of the enteroinvasive E. coli
and  Shigella flexneri virulence plasmids is
sometimes due to plasmid insertion into a
specific site on the chromosome (85,86).
After integration, excision also can be
detected; strains containing precisely excised
plasmids regain virulence, while those with
imprecisely excised plasmids remain
noninvasive. Several of the  Y. pestis
plasmids exhibit similar behavior (87-89).
Integration, which simultaneously maintains
these plasmids in the bacterial genome while
downregulating their genes, may represent a
sophisticated adaptation to the requirements
of different environments or may represent?
stages in the bacterial life cycle. Furthermore,
integration and excision remind us that
strict definitions of “chromosomal” versus
“plasmid-borne” do not always reflect
biological reality.
Foreign DNA Is a Significant Determinant
in Recently Emerged Pathogens
Horizontal gene transfer has been
invoked to explain the origin of
enterohemorrhagic  E. coli ( EHEC), which
causes hemorrhagic colitis and hemolytic
uremic syndrome (90). Like  EPEC,  EHEC
induces striking morphologic changes–called
attaching and effacing (AE) lesions–in host
cells of the small intestine; however, unlike
EPEC,   EHEC contains Shiga-like toxins.
After analyzing the genetic relationships
between many E. coli strains, Whittam and
colleagues proposed that EHEC arose from
an EPEC-like progenitor strain, which then
acquired the prophage-encoded Shiga-like
toxins, thus becoming a new pathogen that
expresses both sets of traits (90).
The new epidemic Vibrio cholerae O139
strain may have emerged after acquisition of
a pathogenicity island (91). Although it
appears that V. cholerae O139 arose from a
strain of the same serotype (O1) that is
causing the ongoing cholera pandemic (O1 El
Tor) (92),  V. cholerae O139 contains an
additional piece of DNA that replaces part of
the O antigen gene cluster of O1 strains (93).
The inserted DNA contains open reading
frames homologous to proteins involved in
capsule and O antigen synthesis, two factors
that distinguish O139 and O1 El Tor, and are
thought to mediate activities important for
pathogenesis and evasion of immunity.
Benefiting From Information About Type III
Secretion and Pathogenicity Islands
Pathogenic bacteria continue to exhibit
impressive genetic flexibility and exchange
and use these abilities to adapt to varied284 Emerging Infectious Diseases Vol. 2, No. 4—October-December 1996
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types of lifestyles within host organisms. It
should be possible to use the information
from studies of pathogenicity islands and
type III secretion systems in the ongoing
characterization of bacterial infections.
When a novel pathogen is isolated, it may be
worthwhile to identify chromosomal regions
specific to it by comparing the gross genomic
structure with that of related organisms,
which may provide a shortcut to the
identification of virulence genes. Likewise,
simple molecular techniques can determine
whether bacteria contain type III secretion
systems, because genes encoding particular
components are highly conserved; perhaps
this procedure should be part of our standard
investigative arsenal as well.
Our knowledge of type III secretion
systems may yield therapeutic benefits. The
contact-dependent systems appear to reside
in pathogenic and not in commensal
bacteria. If this observation reflects a
general truth, antibiotics that target type III
systems may specifically attack intruding
bacteria and spare the normal flora;
therefore, these antibiotics might produce
minimal side effects. In addition, type III
secretion systems will provide new targets
for therapeutic drugs that might not kill the
bacterium but would inhibit the disease
process. We also may be able to exploit this
secretion system, by using appropriately
attenuated bacteria, to prime immunity.
Chimeric proteins—fusions between effector
and other proteins—can be secreted in large
quantities by the type III secretion machinery
and be internalized by host cells; furthermore,
these proteins can elicit an antibody
response in mice (38,94).
The virulence traits of pathogenic
microorganisms at the genetic and molecular
level remind us that bacterial pathogenicity
does not arise by slow adaptive evolution but
by “quantum leaps” (95); therefore, microbes
can acquire complete systems that radically
expand their capabilities to exploit and
flourish in different host environments.
History teaches us that infectious diseases
may change in severity and form, but they
will not simply disappear. Microrganisms
are, after all, survivors, and there is no
escaping our destiny—to be consumed by
them in one way or another. However, the
more we learn about the microbial tactics of
survival, the longer we forestall this destiny.
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